{"CONCEPT_ID":[4194895,4295638,4087235,4167605,43020943,4092969,4095027,4097664,4099476,4147961,4198132,36713464,40481096,42538680,756055,4048727,4246053,4264765,4046263,4098179,36713462,4055657,4064918,4102739,42538811,4353510,42538681],"CONCEPT_PATH":["Procedure by method||Procedure by intent||Screening procedure||Screening for disorder","Protein level - finding||Specific antibody level - finding||Finding of HIV status||HIV CDC stage finding","Procedure by intent||Screening procedure||Screening at times of life||Antenatal screening","NA||Staging and scales||Assessment scales||Barthel index","Screening procedure||Screening for disorder||Chromosome abnormality screening||Fetal chromosomal abnormality screening","Laboratory test||Immunology laboratory test||Clinical immunological test||In vivo test of hypersensitivity","Measurement of substance||Protein measurement||Antibody measurement||Antibody titer measurement","Measurement||Measurement of substance||Protein measurement||Albumin measurement","Tumor marker measurement||Measurement of substance in specimen||Fluid sample AFP level||Alpha-1-Fetoprotein measurement, amniotic fluid","Screening for disorder||Screening for neoplasm||Screening for cancer||Screening for malignant neoplasm of breast","Laboratory test||Hematology procedure||Hematology test||Hematology screening test","Screening procedure||Screening at times of life||Antibody screen||Antenatal screening for isoimmunization","Screening procedure||Screening for neoplasm||Screening for cancer||Screening for malignant neoplasm of prostate","Screening procedure||Screening for neoplasm||Screening for cancer||Screening for malignant neoplasm of stomach","Measurement||Measurement of substance||Measurement of Coronavirus (Coronavirinae subfamily species)||Measurement of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","Screening procedure||Screening for disorder||Screening for neoplasm||Screening for cancer","Procedure by method||Laboratory procedure||Laboratory test||Blood test","Procedure by site||Physical examination||Taking patient vital signs||Blood pressure taking","Measurement||Measurement of substance||Protein measurement||Enzyme measurement","Procedure by method||Laboratory procedure||Laboratory test||Immunology laboratory test","Screening procedure||Screening for developmental disorder||Screening for congenital malformation||Antenatal screening for malformation","Measurement||Measurement of substance||Protein measurement||Serum/plasma protein test","Procedure by intent||Screening procedure||Screening for disorder||Diabetes mellitus screening","Procedure by intent||Screening procedure||Screening for disorder||Screening for cardiovascular system disease","Screening for neoplasm||Screening for cancer||Screening for malignant neoplasm of urinary system||Screening for malignant neoplasm of urinary bladder","Measurement||Measurement of substance||Protein measurement||Globulin measurement","Screening procedure||Screening for neoplasm||Screening for cancer||Screening for malignant neoplasm of intestinal tract"],"NUM_PERSONS":[616,528,440,396,220,220,220,220,220,220,220,220,220,220,220,176,132,132,132,132,132,132,44,44,44,44,44],"PERCENT_PERSONS":[8.97566661809704e-05,7.69342852979746e-05,6.41119044149789e-05,5.7700713973481e-05,3.20559522074894e-05,3.20559522074894e-05,3.20559522074894e-05,3.20559522074894e-05,3.20559522074894e-05,3.20559522074894e-05,3.20559522074894e-05,3.20559522074894e-05,3.20559522074894e-05,3.20559522074894e-05,3.20559522074894e-05,2.56447617659915e-05,1.92335713244937e-05,1.92335713244937e-05,1.92335713244937e-05,1.92335713244937e-05,1.92335713244937e-05,1.92335713244937e-05,6.41119044149789e-06,6.41119044149789e-06,6.41119044149789e-06,6.41119044149789e-06,6.41119044149789e-06],"RECORDS_PER_PERSON":[1.85714285714286,1.66666666666667,1.75,1.77777777777778,1.6,1.6,1.4,1.8,1.7,1.6,1.7,1.6,1.8,1.5,1.9,1.875,1.83333333333333,2,1.66666666666667,1.83333333333333,1.83333333333333,1.83333333333333,1.5,2,1.5,2,2]}
